Curreio, Inc.

Curreio, Inc. is a biotech company based in Japan that focuses on R&D centered around high-resolution structural analysis using a Cryo-electron microscope (Cryo-EM). Founded in 2019, Curreio utilizes this cutting-edge technology to drive drug discovery by efficiently and precisely identifying lead-compounds. The company's Series A investment on 20 March 2023 attracted support from a notable group of investors including Beyond Next Ventures, Ono Venture Investment, DOJIN CAPITAL, 旭化成ファーマ（株）, U-Tokyo Entrepreneur Supporter's Club Incubation Fund. With a focus on Analytics, Biotechnology, and Care Economy industries, Curreio's work holds promise for significant advancements in the biotech sector. With its specialized expertise and recent investment influx, Curreio is poised to make a notable impact in the biotech landscape.